INGREZZA (valbenazine) capsules, for oral use. Initial U.S. Approval: 2017

INGREZZA (valbenazine) capsules, for oral use. Initial U.S. Approval: 2017

INDICATIONS AND USAGE
INGREZZA is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with tardive dyskinesia.
DOSAGE FORMS & STRENGTHS
Capsules: 40 mg
Manufactured By: Neurocrine Biosciences, Inc.
Prescribing Information URL: Click Here

Access to INGREZZA ™ (valbenazine) capsules: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Valbenazine, sold under the trade name Ingrezza, is a medication used to treat tardive dyskinesia.[1] It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.